CellSeed Inc logo

7776 - CellSeed Inc News Story

¥256 2.0  0.8%

Last Trade - 15/01/21

Sector
Healthcare
Size
Micro Cap
Market Cap £28.8m
Enterprise Value £20.8m
Revenue £1.05m
Position in Universe 3259th / 3893

TABLE-CellSeed - 9-MTH group results

Tue 13th November, 2018 7:00am
Nov 13 (Reuters)- 
             CellSeed Inc. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Sep 30, 2018        Sep 30, 2017     Dec 31, 2018 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            543 mln             42 mln            1.17     
                                     (+15.0 pct)                  
  Operating      loss 94 mln        loss 667 mln        20 mln    
  Recurring      loss 94 mln        loss 674 mln        50 mln    
  Net            loss 96 mln        loss 674 mln        40 mln    
  EPS           loss 8.43 yen      loss 67.46 yen      3.50 yen   
  Ann Div                                NIL              NIL     
  -Q2 div            NIL                 NIL                      
  -Q4 div                                NIL              NIL     
  
  NOTE - CellSeed Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=7776.T
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.